Liangjiang Medicine is a new R&D organization with innovative drugs and modified new drugs as the core of R&D.

Liangjiang Medicine’s innovative cancer topical application program will use preparation technology and pre-drug technology to solve the problems of existing topical application preparations or to create unique topical application preparation products to bring better treatment options for patients with early and locally advanced tumors.The Company’s R&D team currently consists of more than 10 core members, including 4 overseas PhDs, and the management team are all senior experts with more than 20 years of experience in new drug development.

Established in September 2015, located in Chongqing International Biological City, Chongqing Liujiang Pharma Technology Co., Ltd.

owns CRO platform for drug development, clinical phase I management and bioassay; in 2016, it was awarded “New Enterprise R&D Organization” by Chongqing Economic and Information Commission, and in 2017, it was approved by Chongqing Economic and Information Commission as the first generic drug quality and efficacy consistency evaluation center in Chongqing.

Established in January 2019, , Changchun Lanjiang Pharmaceutical Technology Co.Ltd.

located in Beihu Science Park of Changchun New Area (National New Area),is a pharmaceutical technology company dedicated to pharmaceutical new product R&D, new drug technology development and transfer, and pharmacy technology services.It’s also the first pharmaceutical research company with MAH established in Jilin Province.The Company has a modern drug R&D laboratory covering an area of 2,600 square meters, equipped with over 100 units (sets) of advanced drug R&D equipment worth up to RMB 30 million.

Established in March 2017, Chongqing Gerui Clinical Research Center Co., Ltd

is committed to building an international and domestic first-class Phase BE/I clinical research center.